Award recordCONTRACT

MDD US OPERATIONS, LLC

PIID 36C26018F0076· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $133,239 net obligations· UEI NKGSYBV5UGN1· KY

Description

APOMORPHINE (APOKYN) 30MG/ML INJECTION 3ML 204 VI

First action · last action
2017-10-18 · 2019-04-05
Transactions
2
First transaction's obligation
$143,810
Base + all options value (sum of deltas)
$133,239
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40284
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$143,810$0Base award · 2017-10-18 · this action $143,810 · running total $143,810Modification P00001 · 2019-04-05 · this action -$10,570 · running total $133,239
  • Base2017-10-18+$143,810= $143,810
  • Mod P000012019-04-05-$10,570= $133,239
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-10-18+$143,810$143,810APOMORPHINE (APOKYN) 30MG/ML INJECTION 3ML 204 VI
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-04-05−$10,570$133,239APOMORPHINE (APOKYN) 30MG/ML INJECTION 3ML 204 VI

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NKGSYBV5UGN1)

AwardOffice · PSC / listingNet obligationsFY
36C26019N0097260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$123,250FY2019
36C24718K0061247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$35,239FY2018
36C24918N4031249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$12,855FY2018
36C24918F3178249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$12,855FY2018
36C24918F2770249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$10,713FY2018
36C24718K0060247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$89,559FY2018

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018F0076_3600_V797D40284_3600 · retrieved 2026-09-26.